Norris Medicines Limited

₹15.00As of Sun 8 Nov 2026, 12:00 UTC
BSE:524414Healthcare
Country India
PE (Fwd) •••
TSR 9Y CAGR (1.25%)
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) (0.40)
PE TTM —
TSR TTM (5.06%)
Mkt cap ₹150.0M
ROIC 0.43%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹15
(2.28%)
(63.63%)
Hold 0|7|2|4|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.16
0.17
0.17
0.16
13.05%
23.69%
8.63%
10.52%
Revenue₹M
9.191
9.301
9.799
9.825
(0.25%)
1.22%
2.57%
5.94%
Peers (US$1.597M)
Cap (US$)
PE
1.637M
12.87x
Capital
TTM
5Y
10Y
Leveragex
0.470
0.122
0.097
EBIT/Intx
1.031
3.893
3.784
Own earn%
21.84
55.51
60.11
Sh yield%
51.22
40.99
41.20
Owners
Insiders/Inst%
1.28
72.87
Short interest%
0.91
SBC / revenue%
3.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
16–21
$1 testx
—
Incr. ROIC%
23